Anthony Hunt - 21 Jul 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
21 Jul 2022
Net transactions value
-$4,300,060
Form type
4
Filing time
22 Jul 2022, 16:25:21 UTC
Previous filing
17 Jun 2022
Next filing
09 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $169,350 +5,000 +2.5% $33.87* 204,315 21 Jul 2022 Direct
transaction RGEN Common Stock Options Exercise $490,990 +15,154 +7.4% $32.40* 219,469 21 Jul 2022 Direct
transaction RGEN Common Stock Sale $4,960,400 -24,802 -11% $200.00 194,667 21 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +5,000 +7.8% $0.000000 69,246 21 Jul 2022 Common Stock 5,000 $33.87 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +15,154 $0.000000* 0 21 Jul 2022 Common Stock 15,154 $32.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
F2 This option is fully vested and exercisable.